<?xml version="1.0" encoding="UTF-8"?>
<ref id="B69-pharmaceuticals-13-00303">
 <label>69.</label>
 <element-citation publication-type="journal">
  <person-group person-group-type="author">
   <name>
    <surname>Tang</surname>
    <given-names>J.M.</given-names>
   </name>
   <name>
    <surname>Min</surname>
    <given-names>J.</given-names>
   </name>
   <name>
    <surname>Li</surname>
    <given-names>B.S.</given-names>
   </name>
   <name>
    <surname>Hong</surname>
    <given-names>S.S.</given-names>
   </name>
   <name>
    <surname>Liu</surname>
    <given-names>C.</given-names>
   </name>
   <name>
    <surname>Hu</surname>
    <given-names>M.</given-names>
   </name>
   <name>
    <surname>Li</surname>
    <given-names>Y.</given-names>
   </name>
   <name>
    <surname>Yang</surname>
    <given-names>J.</given-names>
   </name>
   <name>
    <surname>Hong</surname>
    <given-names>L.</given-names>
   </name>
  </person-group>
  <article-title>Therapeutic Effects of Punicalagin Against Ovarian Carcinoma Cells in Association with Î²-Catenin Signaling Inhibition</article-title>
  <source>Int. J. Gynecol. Cancer</source>
  <year>2016</year>
  <volume>26</volume>
  <fpage>1557</fpage>
  <lpage>1563</lpage>
  <pub-id pub-id-type="doi">10.1097/IGC.0000000000000805</pub-id>
  <?supplied-pmid 27540692?>
  <pub-id pub-id-type="pmid">27540692</pub-id>
 </element-citation>
</ref>
